Inventaire - your friends and communities are your best library

Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies

Published in: PLOS Computational Biology

Date of publication: July 2007

Language: English

Bibliographic databases:

Cites articles 73

Date

Title

Authors

January 1947

The Generalization of `Student's' Problem when Several Different Population Variances are Involved
September 1, 1984

Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone
March 1, 1986

Structure, function, and molecular defects of factor IX.
July 1, 1988

The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity
March 1, 1988

Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds
March 25, 1989

The roles of protein C and thrombomodulin in the regulation of blood coagulation
February 1, 1989

Comparative interactions of factor IX and factor IXa with human platelets
July 1, 1990

Surface-dependent reactions of the vitamin K-dependent enzyme complexes
April 1, 1991

Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs
November 1, 1991

Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model
June 25, 1992

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement
September 1, 1994

A model for the tissue factor pathway to thrombin. II. A mathematical simulation
October 1, 1995

Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin
December 1, 1995

The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa
January 1, 1996

Molecular Interactions of Thrombin
September 1, 1996

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin
June 26, 1997

Robustness in simple biochemical networks
March 1, 1997

Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor
July 1, 1998

Newer concepts of blood coagulation.
January 14, 1999

Robustness in bacterial chemotaxis
August 1, 1999

Biochemistry and physiology of blood coagulation
September 1, 1999

How the protease thrombin talks to cells
March 1, 1999

Blood-borne tissue factor: another view of thrombosis
October 1, 1999

Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats
October 1, 1999

"Normal" thrombin generation
September 1, 1999

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
July 1, 1999

Computational simulation of platelet deposition and activation: I. Model development and properties
July 1, 1999

Computational simulation of platelet deposition and activation: II. Results for Poiseuille flow over collagen
February 10, 2000

A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae

, , ,
September 14, 2000

Thrombin signalling and protease-activated receptors
March 13, 2001

A comprehensive two-hybrid analysis to explore the yeast protein interactome
June 1, 2001

The hemophilias--from royal genes to gene therapy

Article -

Welcome to inventaire

The library of your friends and communities

Learn more